Can We Exploit β-Lactamases Intrinsic Dynamics for Designing More Effective Inhibitors?

Area of Science:

• Microbiology
• Drug Discovery
• Biochemistry

Background:

• Beta-lactamases (BLs) are a primary cause of antimicrobial resistance in Gram-negative bacteria.
• Emerging BLs and mutations rapidly overcome existing antibiotics, leading to a critical shortage of effective treatments.
• Co-expression of diverse BLs and lack of broad-spectrum inhibitors exacerbate the challenge.

Purpose of the Study:

• To review the significance of BL binding site dynamics in enzyme function and inhibitor design.
• To explore allosteric sites and potential allosteric inhibitors as a novel strategy against BL-mediated resistance.
• To highlight the potential of allosteric inhibitors to synergize with traditional inhibitors.

Main Methods:

• Literature review focusing on BL binding site dynamics.
• Analysis of identified allosteric sites in beta-lactamases.
• Discussion of allosteric inhibitor strategies.

Main Results:

• BL binding site dynamics are crucial for catalytic efficiency and the impact of resistance mutations.
• Allosteric sites in BLs have been identified, offering potential targets for novel inhibitors.
• Allosteric inhibitors show promise in overcoming resistance mutations and substrate competition.

Conclusions:

• Understanding BL dynamics is key for designing next-generation inhibitors.
• Allosteric inhibition presents a viable strategy to combat beta-lactamase-mediated resistance.
• Synergistic use of allosteric and traditional inhibitors can restore bacterial susceptibility to existing antibiotics.